NTLA Intellia Therapeutics, Inc.
Healthcare$12.49+0.00%OpenMarket Cap: $1.40B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$26.29
Target (Median)
$25.00
Target Range
$13.00 - $49.00
Upside from current price: 110.4%
Rating Distribution
2 Strong Buy12 Buy9 Hold1 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | maintain | Market Perform | Market Perform |
| 2026-05-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-12 | Wedbush | maintain | Neutral | Neutral |
| 2026-05-12 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-04-28 | Goldman Sachs | maintain | Sell | Sell |
| 2026-04-28 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-04-28 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-04-27 | Chardan Capital | maintain | Buy | Buy |
| 2026-04-27 | Baird | maintain | Neutral | Neutral |
| 2026-03-04 | Jones Trading | upgrade | Buy | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.90 | $259.5M | 17 |
| Sun Dec 31 | $-0.69 | $660.7M | 11 |
| Mon Dec 31 | $4.09 | $1.74B | 4 |
| Tue Dec 31 | $8.94 | $2.72B | 4 |